TABLE 3.

Twenty-one hub pathways across the three groups.

Term	ID	PTZ vs. Con.		Q808 vs. PTZ
		p-value	Enrichment score	p-value	Enrichment score
VEGF signaling pathway	rno04370	0.002	5.985	0.032	3.581
Basal cell carcinoma	rno05217	0.002	5.593	0.036	3.346
Ether lipid metabolism	rno00565	0.008	4.944	0.021	4.437
Malaria	rno05144	0.012	4.135	0.000	14.844
Toxoplasmosis	rno05145	0.015	3.130	0.016	3.745
Graft-versus-host disease	rno05332	0.019	3.499	0.040	3.140
Amphetamine addiction	rno05031	0.020	3.446	0.041	3.092
Leishmaniasis	rno05140	0.021	3.394	0.042	3.046
Renin secretion	rno04924	0.022	3.345	0.044	3.002
Allograft rejection	rno05330	0.022	3.345	0.044	3.002
Asthma	rno05310	0.023	4.212	0.008	7.559
Bile secretion	rno04976	0.024	3.203	0.047	2.875
Focal adhesion	rno04510	0.029	2.309	0.003	4.144
Human papillomavirus infection	rno05165	0.030	2.001	0.006	2.993
Rheumatoid arthritis	rno05323	0.037	2.707	0.008	4.860
Fluid shear stress and atherosclerosis	rno05418	0.038	2.353	0.034	2.815
Renin–angiotensin system	rno04614	0.040	3.159	0.013	5.670
Viral myocarditis	rno05416	0.042	2.584	0.009	4.639
GnRH signaling pathway	rno04912	0.043	2.555	0.009	4.587
Glycine, serine, and threonine metabolism	rno00260	0.044	2.992	0.015	5.371
Bladder cancer	rno05219	0.048	2.843	0.016	5.103